Solventum Corporation/SOLV

$61.95

0.42%
-
1D1W1MYTD1YMAX

About Solventum Corporation

Solventum Corp. is a global healthcare company. Its segments include Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. Medical Surgical is a provider of solutions including advanced wound care, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Dental Solutions provides dental and orthodontic products include brackets, aligners, restorative cements, and bonding agents that span the life of the tooth, including products designed for preventative dental care, direct and indirect restoration, and broad orthodontic needs. Health Information Systems offers healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, speech recognition, and data visualization platforms. Purification and Filtration is a provider of purification and filtration technologies including filters, purifiers, cartridges, and membranes.

Ticker

SOLV

Sector

Healthcare

Trading on

NYSE

Industry

Healthcare Facilities

CEO

-

Employees

22,007

Headquarters

St. paul, United States

SOLV Metrics

BasicAdvanced
$10.65B
Market cap
7.90
P/E ratio
$7.80
EPS
-
Beta
-
Dividend rate
$10.65B
$96.05
$61.56
1.458
0.962
6.469
7.904
1.3
0.913
4.78
6.557
0.82%
0.22%
4.03%
5.76%

SOLV Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
13.35% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$2.04B
-1.83%
Net income
$272M
-40.87%
Profit margin
13.35%
-39.78%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Solventum Corporation stock?

Solventum Corporation (SOLV) has a market cap of $10.65B as of April 17, 2024.

What is the P/E ratio for Solventum Corporation stock?

The price to earnings (P/E) ratio for Solventum Corporation (SOLV) stock is 7.9 as of April 17, 2024.

Does Solventum Corporation stock pay dividends?

No, Solventum Corporation (SOLV) stock does not pay dividends to its shareholders as of April 17, 2024.

When is the next Solventum Corporation dividend payment date?

Solventum Corporation (SOLV) stock does not pay dividends to its shareholders.

What is the beta indicator for Solventum Corporation?

Solventum Corporation (SOLV) does not currently have a Beta indicator.

What is the Solventum Corporation stock price target?

The target price for Solventum Corporation (SOLV) stock is $, which is 100% below the current price of $61.95. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Solventum Corporation stock

Buy or sell Solventum Corporation stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing